Brief: Fibrobiologics Inc Says On May 2, Robert E. Hoffman Resigns As Interim CFO Effective May 14, 2025 - SEC Filing
05/05/2025 21:27
May 5 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS INC - ON MAY 2, ROBERT E. HOFFMAN RESIGNS AS INTERIM CFO EFFECTIVE MAY 14, 2025 - SEC FILING Source text: [ID:n0001641172-25-008680] Further company coverage: FBLG.O ((Reuters.Brief@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts